Neuronal nicotinic receptors in dementia with lewy bodies and schizophrenia: α-bungarotoxin and nicotine binding in the thalamus

Journal of Neurochemistry

Volumn 73, Issue 4, 1999, Pages 1590-1597

  Court, Jennifer ^a,b   Spurden, Dean ^a   Lloyd, Stephen ^a   McKeith, Ian ^a   Ballard, Clive ^a   Cairns, Nigel ^c   Kerwin, Robert ^c   Perry, Robert ^b   Perry, Elaine ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bungarotoxin binding; Dementia with Lewy bodies; Nicotine binding; Psychosis; Schizophrenia; Thalamus

Indexed keywords

ALPHA BUNGAROTOXIN; BRAIN RECEPTOR; CYTISINE; NICOTINE; NICOTINIC RECEPTOR;

ADULT; AGED; ARTICLE; CHROMOSOME 15; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; HUMAN; HUMAN TISSUE; LEWY BODY; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING; THALAMUS; VISUAL HALLUCINATION;

AGED; AGED, 80 AND OVER; BUNGAROTOXINS; DEMENTIA; HUMANS; LEWY BODIES; MIDDLE AGED; NEURONS; NICOTINE; RECEPTORS, NICOTINIC; REFERENCE VALUES; SCHIZOPHRENIA; THALAMUS;

EID: 0032872325     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0731590.x     Document Type: Article

References (76)

1. Adler L. E., Hoffer L. D., Wiser A., and Freedman R. (1993) Normalisation of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry 150, 1856-1861.
2. Adler L. E., Olincy A., Waldo M., Harris J. G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., and Freedman R. (1998) Schizophrenia, sensory gating and nicotinic receptors. Schizophr. Bull. 24, 189-202.
3. Albuquerque E. X., Pereira E. F. R., Bonfante-Cabarcas R., Marchioro M., Matsubayashi H., Alkondon M., and Maelicke A. (1996) Nicotinic acetylcholine receptors on hippocampal neurons: cell compartment-specific expression and modulatory control of channel activity. Prog. Brain Res. 109, 111-124.
4. Andreasen N. C. (1997) The role of the thalamus in schizophrenia. Can. J. Psychiatry 42, 27-33.
5. Bannon A. W., Decker M. W., Holladay M. W., Curzon P., Donnelly-Roberts D., Puttfarcken P. S., Bitner R. S., Diaz A., Dickenson A. H., Porsolt R. D., Williams M., and Arneric S. P. (1998) Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science 279, 77-81.
6. Bentivoglio M., Aggleton J. P., and Mishkin M. (1997) The thalamus and memory formation, in Thalamus, Vol II (Steriade M., Jones E. G., and McCormick D. A., eds), pp. 689-720. Elsevier, Amsterdam.
7. 3H]nicotine binding sites in human brain. J. Neurochem. 50, 1243-1247.
8. Brandel J. P. A., Hirsch E. C., Hersh L. B., and Javoy-Agid F. (1990) Compartmental ordering of cholinergic innervation of the mediodorsal nucleus of the thalamus in human brain. Brain Res. 515, 117-125.
9. 125I]alpha bungarotoxin binding. J. Comp. Neurol. 387, 385-398.
10. 3H) nicotine binding in human postmortem brain. J. Pharmacol. Exp. Ther. 282, 7-13.
11. Buchsbaum M. S., Someya T., Teng C. Y., Abel L., Chin S., Najafi A., Haier R. J., Wu J., and Bunney W. E. (1996) PET and MRI of the thalamus in never medicated patients with schizophrenia. Am. J. Psychiatry 153, 191-199.
12. Chini B., Raimondi E., Elgoyhen A., Moralli D., Balzaretti M., and Heinemann S. (1994) Molecular cloning and chromosomal localization of the human alpha7 nicotinic receptor subunit gene (CHRNA7). Genomics 19, 379-381.
13. Court J. A. and Perry E. K. (1994) CNS nicotinic receptors: therapeutic target in neurodegeneration. CNS Drugs 2, 216-233.
14. Court J. A. and Perry E. K. (1995) Nicotinic receptor distribution in the CNS, in CNS Neurotransmitters and Neuromodulators - Acetylcholine (Stone T. W. ed), pp. 85-104. CRC Press, Boca Raton.
15. Court J. A., Lloyd S., Johnson M., Griffiths M., Birdsall N. J. M., Piggott M. A., Oakley A. E., Ince P. G., Perry E. K., and Perry R. H. (1997) Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Dev. Brain Res. 101, 93-105.
16. Court J. A., Lloyd S., Thomas N., Piggott M. A., Marshall E. F., Morris C. M., Lamb H., Perry R. H., Johnson M., and Perry E. K. (1998) Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience 87, 63-78.
17. Dalack G. W. and Meador-Woodruff J. H. (1996) Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature. Schizophr. Res. 22, 133-141.
18. Freedman R., Hall M., Adler L. E., and Leonard S. (1995) Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiatry 38, 22-33.
19. Freedman R., Conn H., Myles-Worsley M., Orr-Urteger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkin J., Rosenthal J., Waldo M. C., Reimherr F., Wender P., Yaw J., Young D. A., Breese C. R., Adams C., Patterson D., Adler L. E., Kruglyak L., Leonard S., and Byerley W. (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. USA 94, 587-592.
20. Garcia-Rill E., Biedermann J. A., Chambers S. T., Skinner R. D., Mrak R. E., Husain M., and Karson C. N. (1995) Mesopontine neurons in schizophrenia. Neuroscience 66, 321-335.
21. Griffith J. M., O'Neill J. E., Petty F., Garver D., Young D., and Freedman R. (1998) Nicotonic receptor desensitization and sensory gating deficits in schizophrenia. Biol. Psychiatry 44, 98-106.
22. Haroutunian V., Davidson M., Kanof P. D., Perl D. P., Powchik P., Losonczy M., McCrystal J., Purohit D. P., Bierer L. M., and Davis K. L. (1994) Cortical cholinergic markers in schizophrenia. Schizophr. Res. 12, 137-144.
23. Heckers S. (1997) Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems. Schizophr. Bull. 23, 403-421.
24. Heckers S., Geula C., and Mesulam M. M. (1992) Cholinergic innervation of the human thalamus: dual origin and differential nuclear distribution. J. Comp. Neurol. 325, 68-82.
25. Hellstrom-Lindahl E., Winblad B., and Nordberg A. (1993) Muscarinic and nicotinic receptor changes in the cortex and thalamus of brain of chronic alcoholics. Brain Res. 620, 42-48.
26. Hughes J. R. and McHugh P. (1995) Nicotine and neuropsychological disorders: schizophrenia, in Advances in Pharmacological Sciences. Effects of Nicotine on Biological Systems II (Clarke P. B. S., Quik M., Adlkofer F., and Thurau K., eds), pp. 301-305. Birkhäuser Verlag, Basel.
27. Ince P., Irving D., MacArthur F., and Perry R. H. (1991) Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and elderly non-demented control patients. J. Neurol. Sci. 106, 142-152.
28. Jaros E., Hall R., Ince P., and Perry R. H. (1998) Phosphorylated tau is present in ubiquitin positive Lewy neuntes (LN) in the CA2 region of the hippocampus in dementia with Lewy bodies (DLB). Neurobiol. Aging 19 (Suppl. 45), S201.
29. Jones E. G. (1997) Cortical development and thalamic pathology in schizophrenia. Schizophr. Bull. 23, 483-501.
30. Jones G., Sahakian B., Levy R., Warburton D., and Gray J. (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology (Berl.) 108, 485-494.
31. Karczmar A. G. and Richardson D. L. (1985) Cholinergic mechanisms, schizophrenia, and neuropsychiatrie adaptive dysfunctions, in Central Cholinergic Mechanisms and Adaptive Dysfunctions (Singh M. M., Warburton D. M., and Lal I. T., eds), pp. 193-221. Plenum Press, New York.
32. Koelle G. B. (1951) The elimination of enzymatic diffusion artefacts in the histochemical localisation of cholinesterases and a survey of their distribution. J. Pharmacol. Exp. Ther. 103, 153-171.
33. Leonard S., Adams C., Breese C. R., Adler L. E., Bickford P., Byerley W., Coon H., Griffith J. M., Miller C., Myles-Worsley M., Nagamoto H. T., Rollins Y., Stevens K. E., Waldo M., and Freedman R. (1996) Nicotinic receptor function in schizophrenia. Schizophr. Bull. 22, 431-445.
34. Levey A. I., Hallanger A. E., and Wainer B. H. (1987) Cholinergic nucleus basalis neurons may influence the cortex via the thalamus. Neurosci. Lett. 74, 7-13.
35. Lindstrom J., Anand R., Peng X., Gerzanich V., Wang F., and Li Y. (1995) Neuronal nicotinic receptor subtypes. Ann. NY Acad. Sci. 757, 100-116.
36. Lindstrom J., Anand R., Gerzanich V., Peng X., Wang F., and Wells G. (1996) Structure and function of neuronal nicotinic acetylcholine receptors. Prog. Brain Res. 109, 125-140.
37. Lohr J. B. and Flynn K. (1992) Smoking and schizophrenia. Schizophr. Res. 8, 93-102.
38. Marken P. A., Stoner S. C., and Bunker M. T. (1996) Anticholinergic drug abuse and misuse. CNS Drugs 5, 190-195.
39. Marks M. J., Pauly J. R., Gross S. D., Deneris E. S., Hermans-Borgmeyer I., Heinemann S. F., and Collins A. C. (1992) Nicotine binding and nicotinic receptor subunit mRNA after chronic nicotine treatment. J. Neurosci. 12, 2765-2784.
40. McCormick D. A. (1992) Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog. Neurobiol. 39, 337-388.
41. McEvoy J. P. and Lindgren Y. (1996) Smoking and schizophrenia. Drug Dev. Res. 38, 263-266.
42. McGehee D. S. and Role L. (1995) Physiological diversity of nicotinic acetylcholine receptors expressed in vertebrate neurons. Annu. Rev. Physiol. 57, 521-546.
43. McKeith I. G., Galasko D., Kosaka K., Perry E. K., Dickson D. W., Hansen L. A., Salmon D. P., Lowe J., Mirra S. S., Byrne E. J., Lennox G., Quinn N. P., Edwardson J. A., Ince P. G., Bergeron C., Burns A., Miller B. L., Lovestone S., Collerton D., Jansen E. N., Ballard C., de Vos R. A., Wilcock G. K., Jellinger K. A., and Perry R. H. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47, 1113-1124.
44. Mesulam M. M., Guela C., Bothwell M. A., and Hersh L. B. (1989) Human reticular formation: cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons. J. Comp. Neurol. 281, 611-633.
45. Michel G. F. and Moore C. L. (1995) Developmental Psychobiology, p. 337. MIT Press, Cambridge.
46. Mirra S. S., Hegman A., McKeel D., Sclerij S. H., Crain B. J., Brownlee L. M., Nogel F. S., Hughes J. P., van Beele G., and Berg L. (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II. Standardisation of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-480.
47. Mitrofanis J. and Guillery R. W. (1993) New views of the thalamic reticular nucleus in the adult and the developing brain. Trends Neurosci. 16, 240-245.
48. Neves-Pereira M., Bassett A. S., Honer W. G., Lang D., King N. A., and Kennedy J. L. (1998) No evidence for linkage of the CHRNA7 gene region in Canadian schizophrenic families. Am. J. Med. Genet. 81, 361-363.
49. Olincy A., Ross R. G., Young D. A., Roath M., and Freedman R. (1998) Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology 18, 175-185.
50. 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia. Biol. Psychiatry 42, 359-366.
51. Pauly J. R., Marks M. J., Gross S. D., and Collins A. C. (1991) An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J. Pharmacol. Exp. Ther. 258, 1127-1136.
52. Perry E. K. and Perry R. H. (1995) Acetylcholine and hallucinations: disease related compared with drug induced alterations in human consciousness. Brain Cogn. 28, 240-258.
53. Perry E. K., Marshall E., Kerwin J., Smith C. J., Jabeen S., Cheng A. V., and Perry R. H. (1990) Evidence of a monoaminergic: cholinergic imbalance related to visual hallucinations in Lewy body dementia. J. Neurochem. 55, 1454-1456.
54. Perry E., Court J., Goodchild R., Griffith M., Jaros E., Johnson M., Lloyd S., Piggott M., Spurden D., Ballard C., McKeith I., and Perry R. (1998) Clinical neurochemistry: developments in dementia research based on brain bank material. J. Neural Transm. 105, 915-933.
55. Perry R. H. and Perry E. K. (1980) The cholinergic system in Alzheimer's disease, in Biochemistry and Dementia (Roberts P. J., ed), pp. 135-183. John Wiley and Sons, London.
56. Perry R. H., Candy J. M., Perry E. K., Thompson J., and Oakley A. E. (1984) The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations. J. Anat. 138, 713-732.
57. Perry R. H., Irving D., Blessed G., Fairbairn A. F., and Perry E. K. (1990) Senile dementia of Lewy body type: a clinically and pathologically distinct form of Lewy body dementia in the elderly. J. Neurol. Sci. 95, 119-139.
58. Portas C. M., Goldstein J. M., Shenton M. E., Hokama H. H., Wible C. G., Fischer I., Kikinis R., Donnino R., Jolesz F. A., and McCarley R. W. (1998) Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol. Psychiatry 43, 649-659.
59. Ross D. T. and Graham D. I. (1993) Selective loss and sparing of neurons in the thalamic reticular nucleus following human cardiac arrest. J. Cereb. Blood Flow Metab. 13, 558-567.
60. Ross D. T., Graham D. I., and Adams J. H. (1993) Selective loss of neurons from the thalamic reticular nucleus following severe human head injury. J. Neurotrauma 10, 151-165.
61. Rubboli F., Court J., Sala C., Morris C. M., Chini B., Perry E., and Clementi F. (1994) Distribution of nicotinic receptors in the human hippocampus and thalamus. Eur. J. Neurosci. 6, 1596-1604.
62. Sargent P. B. (1993) The diversity of neuronal nicotinic receptors. Annu. Rev. Physiol. 16, 403-443.
63. Satoh K. and Fibiger H. C. (1986) Cholinergic neurons of the laterodorsal tegmental nucleus; efferent and afferent connections. J. Comp. Neurol 253, 277-302.
64. 125I]α-bungarotoxin binding. J. Chem. Neuroanat. 13, 105-113.
65. Stauderman K. A., Mahaffy L. S., Akong M., Velicelebi G., Chavez-Noriega L. E., Crona J. H., Johnson E. C., Elliott K. J., Gillespie A., Reid R. T., Adams P., Harpold M. M., and Corey-Naeve J. (1998) Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations α2β4, α3β4 and α4β4 stably expressed in HEK293 cells. J. Pharmacol. Exp. Ther. 284, 777-789.
66. Sugaya K., Giacobini E., and Chiappinelli V. A. (1990) Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease. J. Neurosci. Res. 27, 349-359.
67. Vita A., Bressi S., Perani D., Invernizzi G., Giobbio G. M., Dieci M., Garbarini M., Del Sole A., and Fazio F. (1995) High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naïve schizophrenic patients. Am. J. Psychiatry 152, 876-882.
68. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., and Swanson L. W. (1989) Distribution of alpha2, alpha3, alpha4 and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 284, 314-335.
69. Waldo M. C., Cawthra E., Alder L. E., Dubester S., Staunton M., Nagamoto H., Baker N., Madison A., Simon J., Scherzinger A., Drebing C., Gerhardt G., and Freedman R. (1994) Auditory sensory gating, hippocampal volume and catecholamine metabolism in schizophrenics and their siblings. Schizophr. Res. 12, 93-106.
70. Wang F., Gerzanich V., Wells G. B., Anand R., Peng X., Keyser K., and Lindstrom J. (1996) Assembly of human neuronal nicotinic receptor α5 subunits with α3, β2 and β4 subunits. J. Biol. Chem. 271, 17656-17665.
71. Warpman U. and Nordberg A. (1995) Epibatidine and ABT 418 reveal selective loss of α4β2 nicotinic receptors in Alzheimer brains. Neuroreport 6, 2419-2423.
72. Weinberger D. R. (1997) On localizing schizophrenic neuropathology. Schizophr. Bull. 23, 537-540.
73. Wesnes K. and Warburton D. W. (1983) Smoking, nicotine and human performance. Pharmacol. Ther. 21, 189-208.
74. Wolkin A., Rusinek H., Vaid G., Arena L., Lafargue T., Sanfilipo M., Loneragan C., Lautin A., and Rotrosen J. (1998) Structural magnetic resonance image averaging in schizophrenia. Am. J. Psychiatry 155, 1064-1073.
75. Xuereb J. H., Perry R. H., Candy J. M., Bonham J. R., Perry E. K., and Marshall E. (1991) Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease. Brain 114, 1363-1379.
76. Yeomans J. S. (1995) Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology 12, 3-16.